U.S., June 14 -- ClinicalTrials.gov registry received information related to the study (NCT07019896) titled 'Minimal Vitrectomy Surgery for Epiretinal Membrane' on June 05.
Brief Summary: This multicenter randomized controlled trial evaluates Minimal Vitrectomy Surgery (MVS) versus conventional vitrectomy for idiopathic epiretinal membrane (ERM). The primary endpoints include visual acuity improvement and cataract progression after 12 months. MVS aims to minimize vitreous removal while ensuring complete membrane removal through adaptive limited vitrectomy.
Study Start Date: Dec. 01, 2024
Study Type: INTERVENTIONAL
Condition:
Epiretinal Membrane
Macular Edema (ME)
Nuclear Cataract
Intervention:
PROCEDURE: Minimal Vitrectomy Surgery
T...